Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 48 Neoplasms 43 Depression 31 Fatigue 30 Prostatic Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma, Follicular 18 Lymphoma, Large B-Cell, Diffuse 17 Multiple Myeloma 16 Carcinoma, Non-Small-Cell Lung 16 Lymphoma, Non-Hodgkin 15 Lung Neoplasms 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Lymphoma, Mantle-Cell 14 Leukemia, Myeloid, Acute 14 Hodgkin Disease 14 Colorectal Neoplasms 14 Burkitt Lymphoma 14 Anxiety Disorders 14 Pain 13 Lymphoma, B-Cell, Marginal Zone 13 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Head and Neck Neoplasms 11 Blast Crisis 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10 Leukemia, Myeloid, Accelerated Phase 10 Leukemia, Hairy Cell 10

Interventions

palbociclib 1 exemestane 1 delta 24-sterol reductase 1 Vinorelbine 1 Therapeutics 1 Tamoxifen 1 Standard of Care 1 Risk Assessment 1 Paclitaxel 1 Letrozole 1 Influenza Vaccines 1 Fulvestrant 1 Focus Groups 1 Epirubicin 1 Drug Therapy 1 Counseling 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Acceptance of Health Care × Therapeutics × Clear all

NCT07024329 2026-04-30

RESPONd

University of Calgary

Phase NA Recruiting

Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡